Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 37 | $4,417,010 |
Sells | 252 | $386,858,208 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jun 2024 16:24 | IOT | Samsara Inc | BICKET JOHN | SEE REMARKS, 10% | 25 Jun 2024 | Sale | 96,000 | 29.4912 | 2,831,155 | I |
26 Jun 2024 16:25 | UPST | Upstart Holdings Inc | DATTA SANJAY | Chief Financial Officer | 24 Jun 2024 | Sale | 1,000 | 21.68 | 21,680 | D |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 25 Jun 2024 | Purchase | 6,685 | 1.45 | 9,693 | I |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 24 Jun 2024 | Purchase | 7,208 | 1.44 | 10,380 | I |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 125 | 235.19 | 29,399 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 138 | 234.66 | 32,383 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 86 | 233.53 | 20,084 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 161 | 232.54 | 37,439 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 74 | 231.59 | 17,138 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 227 | 229.93 | 52,194 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 198 | 229.06 | 45,354 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 96 | 228.3 | 21,917 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 26 | 226.82 | 5,897 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 13 | 225.55 | 2,932 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 9 | 224.17 | 2,018 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 45 | 221.71 | 9,977 | D |
26 Jun 2024 16:26 | PEPG | PepGen Inc | MELLION MICHELLE L | Chief Medical Officer | 24 Jun 2024 | Sale | 9,260 | 18.1887 | 168,427 | D |
26 Jun 2024 16:26 | IOT | Samsara Inc | BISWAS SANJIT | CHIEF EXECUTIVE OFFICER, 10% | 25 Jun 2024 | Sale | 96,000 | 29.4917 | 2,831,203 | I |
26 Jun 2024 16:26 | RVMD | Revolution Medicines Inc | KELSEY STEPHEN MICHAEL | See Remarks | 25 Jun 2024 | Sale | 16,467 | 39.057 | 643,152 | D |
26 Jun 2024 16:26 | RVMD | Revolution Medicines Inc | KELSEY STEPHEN MICHAEL | See Remarks | 24 Jun 2024 | Sale | 200 | 39 | 7,800 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 957 | 234.66 | 224,570 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 863 | 235.19 | 202,969 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 595 | 233.53 | 138,950 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,119 | 232.54 | 260,212 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 511 | 231.59 | 118,342 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,572 | 229.93 | 361,450 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,374 | 229.06 | 314,728 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 666 | 228.3 | 152,048 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 177 | 226.82 | 40,147 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 93 | 225.55 | 20,976 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 66 | 224.17 | 14,795 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 308 | 221.71 | 68,287 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 219 | 235.19 | 51,507 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 242 | 234.66 | 56,788 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 151 | 233.53 | 35,263 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 283 | 232.54 | 65,809 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 129 | 231.59 | 29,875 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 398 | 229.93 | 91,512 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 348 | 229.06 | 79,713 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 169 | 228.3 | 38,583 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 45 | 226.82 | 10,207 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 24 | 225.55 | 5,413 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 17 | 224.17 | 3,811 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 78 | 221.71 | 17,293 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | PYOTT DAVID E I | Director | 24 Jun 2024 | Sale | 7,420 | 221 | 1,639,820 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | PYOTT DAVID E I | Director | 24 Jun 2024 | Sale | 7,470 | 222 | 1,658,340 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | PYOTT DAVID E I | Director | 24 Jun 2024 | Sale | 17,560 | 220 | 3,863,200 | D |
26 Jun 2024 16:28 | MAPS | WM TECHNOLOGY Inc | BAY ANTHONY | Director | 24 Jun 2024 | Sale | 67,797 | 1.0143 | 68,766 | D |
26 Jun 2024 16:29 | MAPS | WM TECHNOLOGY Inc | TAN FIONA | Director | 24 Jun 2024 | Sale | 113,672 | 1.0087 | 114,661 | D |
26 Jun 2024 16:29 | MAPS | WM TECHNOLOGY Inc | GORDON SCOTT | Director | 24 Jun 2024 | Sale | 112,994 | 1.0114 | 114,282 | D |
26 Jun 2024 16:30 | PIII | P3 Health Partners Inc | LEAVITT LEGACY, LLC | 10% | 24 May 2024 | Purchase | 7,974,481 | 0 | 0 | I |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 164 | 321.82 | 52,778 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 886 | 320.0237 | 283,541 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 1,853 | 319.1057 | 591,303 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 25 Jun 2024 | Sale | 697 | 318.4362 | 221,950 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 122 | 319.3333 | 38,959 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 637 | 318.5383 | 202,909 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 935 | 317.5237 | 296,885 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 122 | 316.5652 | 38,621 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 756 | 314.9819 | 238,126 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 591 | 313.9145 | 185,523 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 341 | 312.7522 | 106,649 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Chairperson & CEO | 24 Jun 2024 | Sale | 96 | 310.71 | 29,828 | D |
26 Jun 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | MESA NILDA | Director | 25 Jun 2024 | Sale | 266 | 318.5784 | 84,742 | D |
26 Jun 2024 16:30 | VSTM | Verastem Inc | CALKINS DANIEL | Chief Financial Officer | 24 Jun 2024 | Sale | 28 | 3.15 | 88 | D |
26 Jun 2024 16:30 | MAPS | WM TECHNOLOGY Inc | FREEMAN BRENDA | Director | 24 Jun 2024 | Sale | 90,396 | 1.0102 | 91,318 | D |
26 Jun 2024 16:31 | MAPS | WM TECHNOLOGY Inc | GONZALEZ OLGA | Director | 24 Jun 2024 | Sale | 90,396 | 1.0105 | 91,345 | D |
26 Jun 2024 16:31 | NUVB | Nuvation Bio Inc | CUI XIANGMIN | Director | 25 Jun 2024 | Purchase | 277,895 | 2.97 | 825,348 | I |
26 Jun 2024 16:32 | ESTC | Elastic N.V. | KULKARNI ASHUTOSH | Chief Executive Officer | 24 Jun 2024 | Sale | 9,664 | 109.88 | 1,061,880 | D |
26 Jun 2024 16:32 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 25 Jun 2024 | Sale | 3,000 | 45.37 | 136,110 | D |
26 Jun 2024 16:34 | HCP | HashiCorp Inc | HOLMES MARC | CHIEF MARKETING OFFICER | 24 Jun 2024 | Sale | 13,728 | 33.476 | 459,559 | D |
26 Jun 2024 16:38 | HCP | HashiCorp Inc | WELIHINDA NAVAM | CHIEF FINANCIAL OFFICER | 24 Jun 2024 | Sale | 17,397 | 33.4657 | 582,203 | D |
26 Jun 2024 16:38 | ORGN | Origin Materials Inc | HEIDENMARK COOK PIA JOHANNA | Director | 25 Jun 2024 | Sale | 4,640 | 0.9844 | 4,568 | D |
26 Jun 2024 16:39 | NXDT | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | DONDERO JAMES D | See Remarks, 10% | 25 Jun 2024 | Purchase | 45,552 | 5.09 | 231,860 | I |
26 Jun 2024 16:39 | NXDT | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | DONDERO JAMES D | See Remarks, 10% | 24 Jun 2024 | Purchase | 16,489 | 4.93 | 81,291 | I |
26 Jun 2024 16:39 | PGY | Pagaya Technologies Ltd. | PERROS EVANGELOS | Chief Financial Officer | 25 Jun 2024 | Sale | 11,293 | 12.1461 | 137,166 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)